Studying the effects of secondary metabolites isolated from Cycas thouarsii R.Br. leaves on MDA-MB-231 breast cancer cells
Source abstract
Abstract
The various therapeutic drugs that are currently utilized for the management of cancer, especially breast cancer, are greatly challenged by the augmented resistance that is either acquired or de novo by the cancer cells owing to the long treatment periods. So, this study aimed at elucidating the possible anticancer potential of four compounds 7, 4', 7'', 4'''-tetra-O-methyl amentoflavone, hesperidin, ferulic acid, and chlorogenic acid that are isolated from Cycas thouarsii leaves n-butanol fraction for the first time. The MTT assay evaluated the cytotoxic action of four isolated compounds against MDA-MB-231 breast cancer cells and oral epithelial cells. Interestingly, ferulic acid revealed the lowest IC50 of 12.52 µg/mL against MDA-MB-231 cells and a high IC50 of 80.2 µg/mL against oral epithelial cells. Also, using an inverted microscope, the influence of ferulic acid was studied on the MDA-MB-231, which revealed the appearance of apoptosis characteristics like shrinkage of the cells and blebbing of the cell membrane. In addition, the flow cytometric analysis showed that the MDA-MB-231 cells stained with Annexin V/PI had a rise in the count of the cells in the early and late apoptosis stages. Moreover, gel electrophoresis detected DNA fragmentation in the ferulic acid-treated cells. Finally, the effect of the compound was tested at the molecular level by qRT-PCR. An upregulation of the pro-apoptotic genes (BAX and P53) and a downregulation of the anti-apoptotic gene (BCL-2) were observed. Consequently, our study demonstrated that these isolated compounds, especially ferulic acid, may be vital anticancer agents, particularly for breast cancer, through its induction of apoptosis through the P53-dependent pathway.
Source: europepmc · Quality: candidate unverified · Source record ↗
Research context
OpenAlex topics: Plant Pathogens and Resistance
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Department of Pharmaceutical Sciences, College of Pharmacy, Princess Nourah bint Abdulrahman University, P.O. Box 84428, Riyadh 11671, Saudi Arabia
Department of Pharmacology and Toxicology, Tanta University, Tanta, Egypt
Department of Pharmaceutical Microbiology, Tanta University, Tanta, Egypt
Fujairah Research Centre, sakamkam Road, Fujairah, United Arab Emirates
Department of Pharmacognosy, El Saleheya El Gadida University, Sharkia, Egypt
Department of Pharmacognosy, Tanta University, Tanta, Egypt
References (74)
Show source-provided references
1. 10.3322/caac.2166010.3322/caac.21660 ↗
2. 10.1186/s12916-015-0278-710.1186/s12916-015-0278-7 ↗
3. 10.1021/ab500084g10.1021/ab500084g ↗
4. 10.1177/2050312121103436610.1177/20503121211034366 ↗
5. 10.3389/fphar.2018.0130010.3389/fphar.2018.01300 ↗
6. 10.1016/j.gendis.2022.02.00710.1016/j.gendis.2022.02.007 ↗
7. 10.1186/s40580-019-0193-210.1186/s40580-019-0193-2 ↗
8. 10.4236/jct.2014.5808910.4236/jct.2014.58089 ↗
9. 10.3892/ijo.2018.466110.3892/ijo.2018.4661 ↗
10. 10.3390/cancers1317428710.3390/cancers13174287 ↗
11. 10.1016/j.breast.2022.08.01010.1016/j.breast.2022.08.010 ↗
12. 10.3390/cells809095710.3390/cells8090957 ↗
13. 10.3389/fonc.2022.89165210.3389/fonc.2022.891652 ↗
14. 10.1056/NEJM19940505330180210.1056/NEJM199405053301802 ↗
15. 10.1038/s41392-021-00572-w10.1038/s41392-021-00572-w ↗
16. 10.3390/ijms2404326610.3390/ijms24043266 ↗
17. 10.1016/j.ejmech.2017.07.03410.1016/j.ejmech.2017.07.034 ↗
18. 10.1016/S0031-9422(00)82499-110.1016/S0031-9422(00)82499-1 ↗
19. Abdelaziz A Sonbol F Elbanna T et al. Exposure to sublethal concentrations of benzalkonium chloride induces antimicrobial resistance and cellular changes in Klebsiellae pneumoniae clinical isolates. Microb Drug Resist. 2019;25(5):631–638.10.1089/mdr.2018.0235 ↗
20. 10.1007/s10600-011-0013-310.1007/s10600-011-0013-3 ↗
21. 10.1002/pca.247810.1002/pca.2478 ↗
22. Mata R. Flavonoids, chemistry, biochemistry and applications by ØM Andersen (University of Bergen) and KR Markham (Industrial Research Ltd.). Boca Raton: CRC Press/Taylor & Francis. 2006. xiv+ 1237 pp. 7 × 101/4 in. $249.95. ISBN 0-8493-2021-6. 2007.
23. El-Sayed MA, Al-Gendy AA, Hamdan DI, et al. Phytoconstituents, LC-ESI-MS profile, antioxidant and antimicrobial activities of citrus x limo. N L. Burm. f. Cultivar Variegated Pink Lemon. J Pharm Sci Res. 2017;9:375.
24. El Kawy A, Michel MA, Kirollos CG, et al. M. In vitro MAO-B inhibitory effects of citrus trifoliata L. fruits extract, self-nano-emulsifying drug delivery system and isolated hesperidin: enzyme assay and molecular docking study. Egypt J Chem. 2020;63:897–906.
25. 10.1371/journal.pone.014024210.1371/journal.pone.0140242 ↗
26. 10.17795/jjnpp-486110.17795/jjnpp-4861 ↗
27. 10.1007/s13205-014-0253-610.1007/s13205-014-0253-6 ↗
28. 10.1155/2020/597609010.1155/2020/5976090 ↗
29. 10.3390/plants601001010.3390/plants6010010 ↗
30. 10.1590/S0100-4042201300060001710.1590/S0100-40422013000600017 ↗
31. 10.21608/ejchem.2020.31739.267410.21608/ejchem.2020.31739.2674 ↗
32. 10.5562/cca302610.5562/cca3026 ↗
33. 10.1016/j.arabjc.2014.11.05610.1016/j.arabjc.2014.11.056 ↗
34. 10.1155/2022/142986910.1155/2022/1429869 ↗
35. 10.1016/j.pharmthera.2020.10767010.1016/j.pharmthera.2020.107670 ↗
36. 10.13040/IJPSR.0975-8232.6(10).4103-1210.13040/IJPSR.0975-8232.6(10).4103-12 ↗
37. 10.18632/aging.10093410.18632/aging.100934 ↗
38. 10.1038/s41573-022-00571-810.1038/s41573-022-00571-8 ↗
39. 10.3390/cancers1317436310.3390/cancers13174363 ↗
40. 10.21608/jampr.2020.23512.100210.21608/jampr.2020.23512.1002 ↗
41. 10.1080/16878507.2020.172290810.1080/16878507.2020.1722908 ↗
42. 10.1055/s-0029-124074310.1055/s-0029-1240743 ↗
43. 10.1080/0192623070132033710.1080/01926230701320337 ↗
44. 10.1080/21691401.2022.205619110.1080/21691401.2022.2056191 ↗
45. 10.1098/rsob.20013010.1098/rsob.200130 ↗
46. 10.3389/fcell.2021.64559310.3389/fcell.2021.645593 ↗
47. 10.1158/2159-8290.CD-21-105910.1158/2159-8290.CD-21-1059 ↗
48. 10.1007/s10495-022-01735-y10.1007/s10495-022-01735-y ↗
49. 10.1038/nri360710.1038/nri3607 ↗
50. 10.3390/biology901002110.3390/biology9010021 ↗
51. 10.2147/CHC.S5789310.2147/CHC.S57893 ↗
52. 10.1038/cdd.2012.9310.1038/cdd.2012.93 ↗
53. 10.1002/1097-0320(20010501)44:1<65::AID-CYTO1083>3.0.CO;2-Q10.1002/1097-0320(20010501)44:1<65::AID-CYTO1083>3.0.CO;2-Q ↗
54. 10.4103/0970-1591.11727810.4103/0970-1591.117278 ↗
55. 10.3390/ijms13111402610.3390/ijms131114026 ↗
56. 10.3390/molecules2704132910.3390/molecules27041329 ↗
57. 10.3390/cancers301099410.3390/cancers3010994 ↗
58. Almukainzi M El-Masry TA Negm WA et al. Co-delivery of gentiopicroside and thymoquinone using electrospun m-PEG/PVP nanofibers: In-vitro and In vivo studies for antibacterial wound dressing in diabetic rats. Int J Pharmac. 2022;625:122106.10.1016/j.ijpharm.2022.122106 ↗
59. 10.3390/cancers1309212510.3390/cancers13092125 ↗
60. 10.3389/fonc.2022.98536310.3389/fonc.2022.985363 ↗
61. 10.1007/s10495-022-01780-710.1007/s10495-022-01780-7 ↗
62. 10.3390/encyclopedia204011110.3390/encyclopedia2040111 ↗
63. 10.3390/ph1408075610.3390/ph14080756 ↗
64. 10.3390/antibiotics1012144410.3390/antibiotics10121444 ↗
65. 10.3390/ph1412131310.3390/ph14121313 ↗
66. 10.3390/ijms22231282710.3390/ijms222312827 ↗
67. 10.3390/foods1115223310.3390/foods11152233 ↗
68. 10.2147/JIR.S34578010.2147/JIR.S345780 ↗
69. 10.1186/s12906-016-1328-110.1186/s12906-016-1328-1 ↗
70. 10.3390/jof703018810.3390/jof7030188 ↗
71. 10.1186/s12935-016-0315-410.1186/s12935-016-0315-4 ↗
72. 10.1186/s13020-016-0118-510.1186/s13020-016-0118-5 ↗
73. Koolivand M, Ansari M, Moein S, et al. The inhibitory effect of sulforaphane on the proliferation of acute myeloid leukemia cell lines through controlling miR-181a. Cell J . 2022;24:44.
74. 10.1007/s10616-018-0287-410.1007/s10616-018-0287-4 ↗